<p>Mucopolysaccharidosis II is a rare X-linked recessive disorder caused by deficiency of the lysosomal enzyme iduronate sulfatase, leading to progressive accumulation of glycosaminoglucans in nearly all cell types, tissues, and organs. Patients with MPS II excrete excessive amounts of chondroitin sulfate B (dermatan sulfate) and heparitin sulfate (heparan sulfate) in the urine (McKusick, 1972; Wraith et al., 2008).</p>

<p>[McKusick, V. A. The Mucopolysaccharidoses. Heritable Disorders of Connective Tissue. St. Louis: C. V. Mosby (pub.)   (4th ed.) : 1972. Pp. 556-574.]<br/>
[Wraith, J. E., Scarpa, M., Beck, M., Bodamer, O. A., De Meirleir, L., Guffon, N., Lund, A. M., Malm, G., Van der Ploeg, A. T., Zeman, J. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Europ. J. Pediat. 167: 267-277, 2008.]<br/></p>